Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients

NCT05797467 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

366

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Chemotherapy Effect

Interventions

DRUG: FOLFOX chemotherapy regimens
DRUG: Bevacizumab

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University